By Chris Bailey | Wednesday 19 January 2022
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I see Emma Walmsley – the current (but surely not for much longer) CEO of GlaxoSmithKline (GSK) – is very excited this morning, after the company announced hiring a new Chief Scientific Officer designate who will take the full job in August. I do agree with Emma that the appointment is positive and important, but I do wonder whether there will be also be a newly announced Glaxo CEO come August, irrespective of the company’s big intellectual and R&D push over the next few years. Even if Glaxo shares are back below 17 quid, you know my continuing positive thoughts as mentioned a few days ago HERE. Meanwhile, let’s talk about Burberry (BRBY).